These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 7523237)

  • 21. [Pharmacokinetics and pharmacodynamics of pegylated recombinant human granulocyte colony-stimulating factor in children with acute lymphoblastic leukemia: a prospective control trial].
    Yang WY; Liu TF; Chen XJ; Guo Y; Li T; Qi BQ; Liu F; Chang LX; Ruan M; Liu XM; Zhang L; Zou Y; Chen YM; Zhu XF
    Zhongguo Dang Dai Er Ke Za Zhi; 2020 Nov; 22(11):1172-1177. PubMed ID: 33172550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparative study on the efficacy and safety between pegfilgrastim (PEG-rhG-CSF) and recombinant human granulocyte colony-stimulating factor in promoting hematopoietic recovery after allogeneic hematopoietic stem cell transplantation after hematological malignancy].
    Yang F; Sun XD; Yuan L; Zhang JC; Hu JW; Liu N; Lou X; Su YF; Yu ZY; Chen JL; Li YH; Hu LD; Chen H; Jiang M
    Zhonghua Xue Ye Xue Za Zhi; 2017 Oct; 38(10):831-836. PubMed ID: 29166733
    [No Abstract]   [Full Text] [Related]  

  • 23. Chemical modification of recombinant human granulocyte colony-stimulating factor by polyethylene glycol increases its biological activity in vivo.
    Satake-Ishikawa R; Ishikawa M; Okada Y; Kakitani M; Kawagishi M; Matsuki S; Asano K
    Cell Struct Funct; 1992 Jun; 17(3):157-60. PubMed ID: 1379521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A multicenter phase II trial of primary prophylactic PEG-rhG-CSF in pediatric patients with solid tumors and non-Hodgkin lymphoma after chemotherapy: An interim analysis.
    Huang J; Lu S; Wang J; Jiang L; Luo X; He X; Wu Y; Wang Y; Zhu X; Chen J; Tang Y; Chen K; Tian X; Shi B; Guo L; Zhu J; Sun F; Zhen Z; Zhang Y
    Cancer Med; 2023 Jul; 12(13):14130-14137. PubMed ID: 37183837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neutrophil kinetics of recombinant human granulocyte colony-stimulating factor-induced neutropenia in rats.
    Okada Y; Kawagishi M; Kusaka M
    Life Sci; 1990; 47(15):PL65-70. PubMed ID: 1700253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anaphylaxis caused by pegylated recombinant human granulocyte colony-stimulating factor.
    Chen C; Qi J; Wang J
    J Oncol Pharm Pract; 2023 Apr; 29(3):727-730. PubMed ID: 35833225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant human granulocyte colony-stimulating factor improves the compromised state of recipient mice without affecting the induction of specific tolerance in the cyclophosphamide-induced tolerance system.
    Nishimura Y; Mayumi H; Tomita Y; Eto M; Maeda T; Nomoto K
    J Immunol; 1991 Apr; 146(8):2639-47. PubMed ID: 1707914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical observation of the salvage therapy using pegylated recombinant human granulocyte colony stimulating factor for grade IV neutropenia induced by concurrent chemoradiotherapy].
    Wu F; Wang H; Li N; Guo Y; Cheng Y; Liu Q; Yang X; Wan X; Wang J
    Zhonghua Zhong Liu Za Zhi; 2014 Sep; 36(9):708-12. PubMed ID: 25564064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacokinetics of PEG-rhG-CSF and rHSA-hG-CSF in mice determined with ELISA].
    Ma GC; Chen SQ; Zhu ZH; Huang YS; Pan HQ; Zhou JB
    Yao Xue Xue Bao; 2007 Feb; 42(2):197-200. PubMed ID: 17518051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prolonged circulation of recombinant human granulocyte-colony stimulating factor by covalent linkage to albumin through a heterobifunctional polyethylene glycol.
    Paige AG; Whitcomb KL; Liu J; Kinstler O
    Pharm Res; 1995 Dec; 12(12):1883-8. PubMed ID: 8786961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long survival of leukemic mice by repeated combination treatment of cyclophosphamide and recombinant human granulocyte colony-stimulating factor.
    Tamura M; Nomura H; Ono M; Bessho M; Hirashima K
    Leukemia; 1991 Dec; 5(12):1043-9. PubMed ID: 1723131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic neutropenia. A new canine model induced by human granulocyte colony-stimulating factor.
    Hammond WP; Csiba E; Canin A; Hockman H; Souza LM; Layton JE; Dale DC
    J Clin Invest; 1991 Feb; 87(2):704-10. PubMed ID: 1704019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of 3 mg pegylated recombinant human granulocyte colony-stimulating factor as support to chemotherapy for lung cancer.
    Ji X; Xu L; Pan P; Xu Z; Wang A; Li Y
    Thorac Cancer; 2022 Jan; 13(1):117-125. PubMed ID: 34791805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo effects of recombinant human granulocyte colony-stimulating factor on normal neutrophil function and membrane effector molecule expression.
    Itoh Y; Kuratsuji T; Tsunawaki S; Aizawa S; Toyama K
    Int J Hematol; 1991 Dec; 54(6):463-9. PubMed ID: 1724390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Close association between clearance of recombinant human granulocyte colony-stimulating factor (G-CSF) and G-CSF receptor on neutrophils in cancer patients.
    Terashi K; Oka M; Ohdo S; Furukubo T; Ikeda C; Fukuda M; Soda H; Higuchi S; Kohno S
    Antimicrob Agents Chemother; 1999 Jan; 43(1):21-4. PubMed ID: 9869559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and efficacy of administering reduced doses of pegylated recombinant human granulocyte-colony stimulating factors in patients treated with cisplatin and etoposide for small cell carcinoma: A retrospective study.
    Liu C; Hao Y; Wang L; Meng F; Wen F; Zhong D
    Thorac Cancer; 2021 Apr; 12(8):1154-1161. PubMed ID: 33590721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The role of prophylactic use of pegylated recombinant human granulocyte colony-stimulating factor(PEG-rhG-CSF) in breast cancer receiving adjuvant chemotherapy].
    Zhang JY; Liu YX; Wang H; Mi L; Song GH; Jiang HF; Yan Y; Shao B; Kong WY; Zhang RY; Ran R; Liu XR; Wang J; Lin YT; Li HP
    Zhonghua Yi Xue Za Zhi; 2018 Sep; 98(34):2718-2721. PubMed ID: 30220167
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of recombinant human granulocyte colony-stimulating factor on variations of morphologically identifiable bone marrow cells in myelosuppressed mice.
    Kabaya K; Kusaka M; Seki M
    In Vivo; 1994; 8(6):1033-9. PubMed ID: 7539636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pegylated recombinant human granulocyte colony-stimulating factor regulates the immune status of patients with small cell lung cancer.
    Sun J; Bai H; Wang Z; Duan J; Li J; Guo R; Wang J
    Thorac Cancer; 2020 Mar; 11(3):713-722. PubMed ID: 32020764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of rhG-CSF scheduling on megakaryocytopoietic recovery following 5-fluorouracil-induced hematotoxicity in splenectomized B6D2F1 mice.
    Scheding S; Media JE; Nakeff A
    Stem Cells; 1998; 16(2):144-51. PubMed ID: 9554039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.